OSCR — Oscar Health Cashflow Statement
0.000.00%
Last trade - 00:00- $4.03bn
- $2.46bn
- $5.86bn
- 35
- 46
- 94
- 60
Annual cashflow statement for Oscar Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -261 | -407 | -571 | -610 | -271 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 27.6 | 43.9 | 128 | 116 | 160 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 61.7 | 574 | 247 | 859 | -192 |
| Change in Accounts Receivable | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Gains / Losses on Investment Securities | |||||
| Change in Reinsurance Receivable | |||||
| Change in Reinsurance Payable | |||||
| Change in Unearned Premiums | |||||
| Cash from Operating Activities | -165 | 223 | -182 | 380 | -272 |
| Capital Expenditures | -26 | -14 | -25.9 | -29 | -25.6 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 177 | -331 | -749 | -198 | 603 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 151 | -345 | -775 | -227 | 577 |
| Financing Cash Flow Items | 0 | -4.84 | -15.2 | -5.19 | 2.49 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2.12 | 612 | 1,239 | 301 | 6.45 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -17 | 490 | 282 | 455 | 311 |